FLT1 and endothelial dysfunction: Flt-1, an inhibitor of the vascular endothelial growth factor pathway which promotes endothelial dysfunction, has been shown to be increased acutely in COVID-19 (18) but its persistent elevation in the post-COVID setting is a novel finding of our study.